Business model of the biological chain in the ETF industry? I am very much curious about the profit model of the various players along the biological chain in the ETF industry... for example, we are making the biggest amount of money in the chain? And which players are making less amount of money? Any industry insider here cares to shed some lights? Thanks a lot!